[Decrease of pulmonary phosphatidylglycerol in the fetuses of rats made diabetic by streptozotocin]

Area of Science:

• Biochemistry
• Perinatology
• Endocrinology

Context:

• Gestational diabetes mellitus (GDM) is a significant concern in pregnancy, potentially impacting fetal development.
• Previous studies indicated altered phospholipid profiles in amniotic fluid of human fetuses from diabetic mothers.
• Rat models provide insights into the mechanisms of diabetic complications during pregnancy.

Purpose:

• To investigate the effects of severe maternal diabetes on fetal lung phospholipid composition in a rat model.
• To analyze the levels of phosphatidylglycerol (PG) and phosphatidylinositol (PI) in fetal rat lungs.
• To correlate observed phospholipid changes with fetal hyperglycemia and hypoinsulinemia.

Summary:

• Fetal rat lungs (gestational day 21.5) from streptozotocin-induced diabetic mothers exhibited a 55% decrease in phosphatidylglycerol (PG) and a 60% increase in phosphatidylinositol (PI).
• These alterations in lung surfactant phospholipids are similar to those observed in human amniotic fluid from diabetic pregnancies.
• The observed changes are hypothesized to result from direct effects of fetal hyperglycemia, potentially mediated by increased blood myoinositol, rather than reactive hyperinsulinemia.

Impact:

• Provides evidence for direct biochemical alterations in fetal lung development due to maternal diabetes and fetal hyperglycemia.
• Highlights the potential role of myoinositol in mediating the effects of glucose excess on fetal lung phospholipid synthesis.
• Contributes to understanding the pathogenesis of respiratory distress syndrome in infants born to diabetic mothers.